Brian Marckx, CFA, is the Senior Med-Tech Analyst and Director of Research with Zacks Small-Cap Research. He has nearly 25 years’ experience as an analyst in both buy and sell-side roles and in fixed-income, structured finance and equity asset classes. Subsequent to joining Zacks in 2007 as a large cap pharma and biotechnology analyst, Brian has gained more than a decade’s worth of experience covering over 100 small and micro-cap companies in the medical technology space. The focus of his coverage has included every sub-industry within med-tech and spanned a wide range of biologics, chemicals, devices, diagnostics, equipment, labs, products, services, software, supplies and more.

Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities' institutional trading desks where he specialized in the healthcare and industrials industries. Prior to that he was an analyst in corporate finance at First Union National Bank. Brian has been quoted in numerous publications including The Wall Street Journal, Barron's, Bloomberg-Businessweek and Kilpinger and his work has been cited in various market studies and working papers including those from Massachusetts Institute of Technology, Deloitte & Touche and Pharmaceutical Manufacturing. Brian graduated with a B.S. in Finance from St. John Fisher College and received his MBA from Wake Forest University. He is a holder of the Chartered Financial Analyst (CFA) designation.